.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Argus Health
Citi
US Army
Fish and Richardson
Cantor Fitzgerald
McKesson
Cerilliant
Fuji
Chubb

Generated: July 29, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: poractant alfa

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Chiesi Usa Inc
CUROSURF
poractant alfa
SUSPENSION;INTRATRACHEAL020744NDAChiesi USA, Inc.10122-510-011.5 mL in 1 VIAL, GLASS (10122-510-01)
Chiesi Usa Inc
CUROSURF
poractant alfa
SUSPENSION;INTRATRACHEAL020744NDAChiesi USA, Inc.10122-510-033 mL in 1 VIAL, GLASS (10122-510-03)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Baxter
Argus Health
Merck
QuintilesIMS
UBS
Accenture
Colorcon
Teva
Queensland Health

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot